Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD0837 Feasibility Study in AF Patients Unable/Unwilling to Take VKA
NCT00623779Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Oct 2007
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of atecegatran metoxil in Atrial fibrillation (AFib), sponsored by AstraZeneca. Started Oct 2007; status: completed.
02
Drugs
atecegatran metoxil
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00623779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00623779.